relative bioavailability

OBJECTIVE To study the relative bioavailability of mecobalamin Tablets in healthy volunteers.

目的:研究甲钴胺片在健康志愿者体内的相对生物利用度.

Dissolution rate of Aciclovir solid dispersion and its relative bioavailability in human

固体分散无环鸟苷胶囊剂溶出度及人体内生物利用度

Objective To investigate the pharmacokinetics and relative bioavailability of the pH-dependent ( T1) and non-pH-dependent ( T2) sustained-release metformin hydrochloride pellets.

目的评价pH依赖型盐酸二甲双胍缓释微丸（T1）和非pH依赖型盐酸二甲双胍缓释微丸（T2）在健康人体内的药代动力学和相对生物利用度。

Objective : To assess the relative bioavailability of gatifioxacin methane-sulfonate capsules versus tablets.

目的: 评价甲磺酸加替沙星胶囊剂对片剂的相对生物利用度.

Study on the pharmacokinetics and relative bioavailability of penicillin V potassium in healthy volunteers

青霉素V钾健康人体药物动力学及相对生物利用度

Objective To evaluate the relative bioavailability and bioequivalence of tset tinidazole tablets.

目的评价不同厂家替硝唑片的相对生物利用度和生物等效性.

OBJECTIVE: To study the relative bioavailability and bioequivalence of glucosamine indometacin enteric-coated tablets in 20 healthy volunteers.

目的：研究po氨糖美辛肠溶片在20名健康志愿者体内的相对生物利用度和生物等效性。

Human pharmacokinetics and relative bioavailability of tamoxifen citrate oral solution Methods: The Sodium Citrate be used ases the Defloculating agents.

枸橼酸他莫昔芬口服液的人体药物动力学及相对生物利用度方法：加入枸橼酸钠作为反絮凝剂。

RESULTS: The relative bioavailability of sustained release Pse was ( 100 3±7 496 ) %.

结果: Pse缓释片的相对生物利用度为 ( 100.3±7.496 ) %.

The relative bioavailability of omeprazole capsule was ( 105.00 ± 30.08)%.

ml-1。受试制剂对参比制剂的相对生物利用度为（105.00±30.08）%。

Pharmacokinetics and Relative Bioavailability of Metformin-glibenclamide Release Tablets; Determination of two components in metformin hydrochloride and glibenclamide tablets by ion-pair HPLC method

格列本脲二甲双胍片健康人体药动学和相对生物利用度研究二甲双胍格列本脲片中两种成分的离子对HPLC法测定

β-carotene determined in serum by HPLC and its relative bioavailability

HPLC测定血清中β-胡萝卜素及其相对生物利用度研究

CONCLUSION The mean relative bioavailability is 142.29%. The AUC of the dispersible tablets are significantly higher than that of capsules ( P < 0.05). The test and reference formulations are not bioequivalent.

结论盐酸伊曲康唑分散片的平均相对生物利用度为142.29%，较斯皮仁诺有明显提高（P

RESULTS The relative bioavailability of atenolol in test were 100.6% ± 33.0%.

结果AT的相对生物利用度为100.6%±33.0%。

AIM: To study the relative bioavailability of domestic fluoxetine hydrochloride ( Flu) capsules.

目的：对国产盐酸氟西汀（Flu）胶囊进行相对生物利用度研究。

Aim: To study the pharmacokinetics and relative bioavailability of penicillin ⅴ potassium in healthy volunteers.

目的：研究青霉素V钾颗粒剂在健康人体中的相对生物利用度，评价其生物等效性。

Compared with reference formulation, the relative bioavailability ( F) of test formulation was 100.6 ± 13.1%.

受试药与参比药比较，相对生物利用度F为100.6±13.1%。

Objective To study the relative bioavailability and bioequivalence of omeprazole Enteric-coated capsules in healthy volunteers.

目的研究奥美拉唑肠溶胶囊的人体相对生物利用度和生物等效性.

Relative bioavailability of two products of cefaclor capsules ( referred to as T and R) in sera of eight healthy male volunteers were determined by high performance liquid chromato-graphy.

用高效液相色谱法，测定健康男性志愿者8名，血清中2种头孢克罗胶囊（T药、R药）的药物浓度，进行相对生物利用度研究。

The relative bioavailability of the tested fluconazole was ( 104.3 ± 8.5)%.

各药代动力学参数无显著性差异（P>0.05）。试验制剂氟康唑胶囊相对生物利用度F为（104.3±8.5）%。

In addition, as comparison with subcutaneous injection of insulin, the relative bioavailability was 12.67% calculated by area the curve of serum insulin concentration versus time profile after oral administration of the insulin-liposomes double-coated with chitosan and CEC to beagle dogs.

另外，在beagle狗降血糖实验中，根据皿清胰岛素浓度-时间曲线的曲线下面积（AUC）计算CH&CEC双层包覆的胰岛素脂质体ig给药的相对生物利度为12.67%。

relative bioavailability of ophiopogon japonicus saponin enteric microsphere in rats

液质联用研究麦冬皂苷肠溶微球在大鼠体内的相对生物利用度

The relative bioavailability of acetaminophen and codeine was 99.97 % ± s 10.55 % and 100.73 % ± s 7.85 % respectively.

扑热息痛和可待因的相对生物度分别为99.97%±s10.55%,100.73%±s7.85%.

Pharmacokinetics and relative bioavailability of the enalapril maleate tablets Innovation strategy for rationale and clinical significance of a new combination of drugs: enalapril maleate and folic acid tablets

马来酸依那普利片的药动学及相对生物利用度复方I类新药依那普利叶酸片的创新思路

OBJECTIVE: To study the relative bioavailability of cyclosporine A suppository.

目的：研究环孢素A栓剂与环孢素A口服液的相对生物利用度。

CONCLUSION: The statistical analysis for the pharmacokinetic parameters showed that there was no significant difference between tablet and capsule ( P> 0.05). The relative bioavailability of tablets was 99.66%.

结论：经统计学分析表明，片剂与胶囊剂之间的药动学参数无显著性差异（P＞0.05），片剂相对于胶囊的生物利用度为99.66%。

Studies on relative bioavailability and pharmacokinetics of coenzyme-Q_ ( 10) tablets

辅酶Q（10）片药动学与人体相对生物利用度试验

Relative bioavailability of acetaminophen nasal drops in human volunteers by reversed phase HPLC

HPLC测定对乙酰氨基酚鼻腔滴剂的人体相对生物利用度

The relative bioavailability of domestic MINO. HC1 is 97.75 ± 22.43%.

国产MINO·HCl相对生物利用度97.75±22.43%。

The relative bioavailability of calcium carbonate tablet was ( 102. 92 1 13. 21)%.

以2种制剂服药后4h的尿钙总排泄量相比，碳酸钙片的相对生物利用度为（102.92±13.21）%。